Mimedx (MDXG) Notes Payables (2010 - 2011)
Mimedx's (MDXG) quarterly Notes Payables came in at $1.3 million in Q4 2011, up 221.24% year-over-year from $403432.0 in Q4 2010, and up 24.44% quarter-over-quarter from $1.0 million in Q3 2011.
Powered by 
Analysis
Mimedx (MDXG) Notes Payables (2010 - 2011) Analysis & Trends
Mimedx has disclosed Notes Payables across 2 years of filings, most recently posting $1.3 million for Q4 2011.
- In Q4 2011, Notes Payables rose 221.24% year-over-year to $1.3 million; the TTM figure through Dec 2011 stood at $1.3 million (up 221.24% YoY), while the FY2011 annual figure was $1.3 million, up 221.24% from the prior year.
- Notes Payables came in at $1.3 million for Q4 2011 at Mimedx, up from $1.0 million in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $1.3 million in Q4 2011 to a low of $45540.0 in Q2 2011.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Mimedx | 679.12 Mn | 543.28 Mn | 44.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2011 | 1.30 Mn |
| Sep 30, 2011 | 1.04 Mn |
| Jun 30, 2011 | 45,540.00 |
| Dec 31, 2010 | 403,432.00 |